Acetylated HOXB13 Regulated Super Enhancer Genes Define Therapeutic Vulnerabilities of Castration-Resistant Prostate Cancer.

Saved in:
Bibliographic Details
Title: Acetylated HOXB13 Regulated Super Enhancer Genes Define Therapeutic Vulnerabilities of Castration-Resistant Prostate Cancer.
Authors: Nguyen DT; Division of Urologic Surgery, Washington University in St. Louis, St. Louis, Missouri.; Department of Surgery, Washington University in St. Louis, St. Louis, Missouri.; Mayo Clinic Graduate School of Biomedical Science, College of Medicine & Science, Rochester, Minnesota., Yang W; Genome Technology Access Center, Department of Genetics, Washington University in St. Louis, St. Louis, Missouri., Renganathan A; Division of Urologic Surgery, Washington University in St. Louis, St. Louis, Missouri.; Department of Surgery, Washington University in St. Louis, St. Louis, Missouri., Weimholt C; Department of Pathology and Immunology, Washington University in St. Louis, St. Louis, Missouri., Angappulige DH; Division of Urologic Surgery, Washington University in St. Louis, St. Louis, Missouri.; Department of Surgery, Washington University in St. Louis, St. Louis, Missouri., Nguyen T; Division of Urologic Surgery, Washington University in St. Louis, St. Louis, Missouri.; Department of Surgery, Washington University in St. Louis, St. Louis, Missouri.; Cancer and Cell Biology Graduate Program, Baylor College of Medicine, Houston, Texas., Sprung RW; Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, St. Louis, Missouri., Andriole GL; Division of Urologic Surgery, Washington University in St. Louis, St. Louis, Missouri.; Department of Surgery, Washington University in St. Louis, St. Louis, Missouri.; National Capital Region, Johns Hopkins Medicine, Sibley Memorial Hospital, Washington, District of Columbia.; Siteman Cancer Center, Washington University in St. Louis, St. Louis, Missouri., Kim EH; Division of Urologic Surgery, Washington University in St. Louis, St. Louis, Missouri.; Department of Surgery, Washington University in St. Louis, St. Louis, Missouri.; Siteman Cancer Center, Washington University in St. Louis, St. Louis, Missouri., Mahajan NP; Division of Urologic Surgery, Washington University in St. Louis, St. Louis, Missouri.; Department of Surgery, Washington University in St. Louis, St. Louis, Missouri.; Siteman Cancer Center, Washington University in St. Louis, St. Louis, Missouri., Mahajan K; Division of Urologic Surgery, Washington University in St. Louis, St. Louis, Missouri.; Department of Surgery, Washington University in St. Louis, St. Louis, Missouri.; Siteman Cancer Center, Washington University in St. Louis, St. Louis, Missouri.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Sep 15; Vol. 28 (18), pp. 4131-4145.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1557-3265
DOI:10.1158/1078-0432.CCR-21-3603